Deals and recent developments offering provides an exhilarating pavement for the healthcare companies which sight to expand their boundaries and ought to capture the most of the existing market. This helps in realizing the current potential of the ongoing market transactions. They do stand as a treasured opportunity for both the major and minor companies to fasten their growth, strengthen their position and transform according to the growth. GervanoRA Data Services (GDS) aims in portraying the existing deals and developments on day to day basis which promise to assist the emerging companies to capture the insights which will drive them to craft decisions for their long term growth.
GDS provides an extensive list of deals, which can be segregated into pharma, medical device and biotechnology sectors. We broadly classify our database into variety of segments depending on the type of agreements that occurred in-between the companies involved.
Our Deals Database is designed sophisticated to track all the deals in required segments, like indication based, therapeutic area, deal value, type of deal, company name and country wise, so that one can easily analyze the M&A Deal activities and segments.
Why Choose GDS Deals Database?
• Specific to Healthcare Domain (Pharma & Medical Device)
• Customization as per Clients Requirements
• Analyst View and Monthly Reviews
• Pharmaceutical Companies
• Medical Device Companies
• Biotechnology Companies
• Investors (Banks)
• Research Institutes
• Venture Capital Firms
• Healthcare Domain Investment Advisors
• Principal Investigators
• Top level Executives
Fresenius Medical Care to Acquire NxStage Medical, Inc. to Strengthen Its Vertically Integrated Dialysis BusinessGenesis Biotechnology Group Acquires Assets of 4path, Ltd to Expand their Diagnostic BranchGlobus Medical Acquires Robotics Developer KB MedicalInvitae Acquire Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of LifeJohnson & Johnson Vision Announces Agreement to Acquire TearScienceMazor Robotics and Medtronic Enter Next Phase of Strategic Partnership; Medtronic to Make a $40 million Third Tranche Investment in MazorMerck to Acquire Natrix Separations to Advance Next-Generation Processing CapabilitiesPacBio Announces New Agreement With Novogene To Purchase Ten Sequel Systems – Increases Novogene’s Capacity to Run 20 Sequel Systems at a TimePhilips and HeartFlow Announce Global Collaboration AgreementRTI Surgical Divests Cardiothoracic Closure Business to A&E Medical Corporation for up to $60 MillionSkyline Medical Signs Definitive Merger Agreement with CytoBioscienceStraumann enters the orthodontics field and strengthens digital capabilitiesTissue Regenix Acquires CellRight TechnologiesZEISS continues to advance digitalization of eye careBD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sexually-Transmitted PathogensBIHLERMED AND LINEUS MEDICAL PARTNERSHIP WILL ADVANCE COMFORT AND SAFETY OF IV PATIENTSCohera Medical, Inc. Announces Exclusive Distribution Agreement for Cohera’s Sylys Surgical Sealant in JapanEndologix Announces Collaboration Agreements with Japan Lifeline for the Development and Com mercialization of Thoracic Endovascular Systems in JapanFitbit’s new partnership will bring diabetes monitoring to the Ionic smartwatchFrazier Healthcare Partners Acquires Northfield MedicaliQor Partners with Connected Health Innovator Nuvo Group to Deliver Healthier, Happier Pregnancies to Women WorldwideNuVasive Announces Acquisition of Vertera SpineNuvoAir Partners with Global Pharmaceutical Company to Help Physicians Early Diagnose and Monitor Respiratory PatientsOptMed Obtains Strategic Investment and License Agreement with SynecounSmiths Medical and Sommetrics Sign Distribution Agreement for New Airway Management SystemTeleflex Incorporated to Acquire NeoTractThe Cooper Companies Announces Definitive Agreement to Acquire PARAGARD IUD from TevaBoston Scientific Announces Agreement to Acquire Apama MedicalCellectar Biosciences and Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug ConjugatesChina Biologic Agrees to Acquire TianXinFu from PWMCryoLife Announces Definitive Agreement to Acquire JOTECiBio Announces Manufacturing Collaboration with Aethlon MedicalIntegra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & JohnsonMayo-Boston Scientific Collaboration Advances with New Heart Surgery DevicePatrona Medical and Kopis develop Medical Device utilizing Zipit’s IoT platformTheraclion Announces Exclusive Distribution Agreement with EDAP TMS FranceAmbu Announces Acquisition of invendo medical GmbHVEXIM to be Acquired by Stryker CorporationSalter Acquires IntuBrite, Parker Medical and InnoMed Technologies to Expand Airway PortfolioArthrosurface acquires an acellular dermal technology from WASAS, LLCCryoLife Announces Definitive Agreement to Acquire JOTECBracco Imaging acquires SurgVision expanding into the innovative field of fluorescence imaging-guided surgeryVyaire Medical Acquires Revolutionary Medical Devices, Inc.EnteroMedics Announces Acquisition Of ReShape MedicalCHF Solutions Signs International Distribution and Services Agreement with Singapore-based TRANSMEDIC Pte Ltd.Dance Biopharm and Phillips-Medisize Enter into Joint Development Agreement for Advanced Inhaled Insulin DeliveryNcardia and Evotec Entered a Licencing Agreement for Disease Modelling Using iPS CellsNanoVibronix Announces Exclusive UK Distributor for PainShield Providing Patients an Alternative to Opioids and SurgeryIsraeli startup partners with GE to help patients get quicker ultrasound readsTelix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing PartnershipSiemens Healthineers Announces Acquisition of Fast Track DiagnosticsEckert & Ziegler BEBIG Purchases Manufacturer of X-Ray DevicesEstablishment Labs and OBP Medical Announce Partnership to Deliver Innovative New Tool for Advanced Breast Aesthetics ProceduresTakeda and Portal Instruments Announce Collaboration to Develop Needle-Free Drug Delivery DeviceMedigus Announces Distribution Agreement with Micro-Tech Europe for the MUSE System in GermanyMedidata Expands Partnership with CytomX Therapeutics to Centralize Management of Regulated and Nonregulated ContentGE Healthcare and Nuance Partner with NVIDIA to Bring AI to Medical ImagingRimidi and Lilly Collaborate to Personalize Solutions for People Using InsulinNanoVibronix Announces Morulaa HealthTech as its Regulatory & Marketing Partner in IndiaThe Qt Company Partners with Quantitative Imaging Systems and KDAB to Advance Cancer ResearchbioMérieux, Inc. and McKesson Medical-Surgical Announce Distribution AllianceSekisui Diagnostics Enters Strategic Alliance with Mesa Biotech Inc. for Molecular POC Testing SystemAgendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint BluePrint Breast Cancer Kit Co-Validation StudyGenomic Health Announces Research Collaboration with Janssen Pharmaceuticals to Evaluate the Oncotype DX Genomic Prostate Score Test for Potential Drug DevelopmentBiocartis Group NV: Biocartis and Amgen Sign Companion Diagnostic Agreement for Idylla(TM) RAS Biomarker TestsPathoQuest and Mayo Clinic Enter into an Agreement to Conduct Study of iDTECT Blood in Patients with Febrile NeutropeniaSPECTRAL TO LAUNCH TORAYMYXIN/EAA IN CANADA IN Q1 2018Medifirst Solutions Announces Agreement With Life Science Quest, LLC.Blue Oak and PsychoGenics Announce a Drug Discovery PartnershipEkso Bionics Partners with HASOMED to Launch Functional Electrical Stimulation (FES) for the EksoGT ExoskeletonCombination of Exoskeleton and RehaStim2 FES Technology Provide BreakthroughUnderwood Foundation, International Biophysics Partner to Provide AffloVests to 50 CF PatientsNuVasive To Acquire SafePassageAgendia and Bluebee Partner to Bring New NGS-based MammaPrint BluePrint Breast Cancer Kit to MarketEIT Emerging Implant Technologies Announces Agreement with HCABodycad Announces EU Distribution and Consulting Agreement with OrthoGrowChondroMimetic Update: First Partner Deal Agreed with South Korean PartnerCentinel Spine Completes Acquisition of prodisc AssetsiCan:Israel-Cannabis to Bring FDA Approved Nebulizers to the Medical Cannabis MarketNanoVibronix Announces IMS Ultrasound (UK) Ltd as its Exclusive UK Distributor for UroShield Following Successful Interim Trial ResultsFuse Medical, Inc. Signs Definitive Purchase Agreement to Acquire CPM Medical Consultants, LLCSkyline Medical and Helomics expand into Next Generation Sequencing for Personalized MedicineBD Completes Bard Acquisition, Creating New Global Health Care LeaderDilon Technologies Inc. acquires the CoPilot VL video laryngoscope, a premier and award-winning airway management devicevTv Therapeutics Announces Licensing Agreement with Hangzhou Zhongmei Huadong Pharmaceutical Co. to Rights for vTv’s GLP-1r Agonist Diabetes Program in China and Other Pacific Rim TerritoriesDigirad Announces Sale of its MDSS Service Contracts to Philips NorthEndonovo Therapeutics Acquires Assets of Electroceuticals Developer, Rio Grande Neurosciences, and Settles LawsuitWright Medical Group N.V. Announces Acquisition of IMASCAP SASThe Cooper Companies Acquires Paragon Vision SciencesEntellus Medical to be sold to Stryker for $622MZealand Pharma boosts collaboration with Beta Bionics to advance development of its dasiglucagon in the iLetTMMedtronic purchases Galway medical device company for almost €40 millionTransEnterix Announces Global SurgiBot System AgreementEdwards Acquires Harpoon MedicalLivaNova to Acquire ImThera Medical, IncSmith & Nephew completes acquisition of tissue regeneration developer Rotation Medical Inc.Sensorion and Cochlear Announce Collaboration to Study Combination Therapies for Cochlear Implant Patients
Aclaris Therapeutics Acquires Confluence Life Sciences, Inc.Aptevo Therapeutics Signs Agreement for Up to $74.5 Million to Sell Hyperimmune Commercial ProductsAstraZeneca and Takeda establish collaboration to develop and commercialize MEDI1341 for Parkinson’s diseaseBristol-Myers Squibb and Daiichi Sankyo Announce Research Collaboration to Evaluate Opdivo (nivolumab) and DS-8201 in HER2-Expressing Breast and Bladder CancersBristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen oncology Pipeline Focus on Innate ImmunityCancer Genetics Announces Transformative and Accretive Acquisition of vivoPharm, a Global Oncology & Immuno-Oncology Discovery Services CompanyCantel Medical Acquire BHT Group in GermanyCempra and Melinta Announce Merger to Form Leading, Vertically Integrated Commercial-Stage Anti-Infectives CompanyCerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy PlatformDaiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitorfor Solid TumorsDermira Enters into Agreement to License Exclusive, Worldwide Rights to LebrikizumabDr. Reddy’s Laboratories announces the out-licensing of DFD-06 to Encore dermatologyGalena Biopharma Enters into Merger Agreement with SELLAS Life Sciences GroupGenmab and Seattle Genetics to Co-develop Tisotumab Vedotin for Solid TumorsGilead Sciences Acquire Kite Pharma for $11.9 BillionInsilico establishes collaboration with GSK to discover novel biological targets and moleculesJohnson & Johnson Announces Partnership with CSIR-IMTECH to Develop Innovative new TB TreatmentsJazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate ProductsMallinckrodt to Acquire InfaCare Pharmaceutical Corporation and Stannsoporfin, Its Proprietary Therapy In Late-Stage Development For Treatment Of Newborns At Risk For Developing Severe JaundiceMundipharma and CellAct announce new deal for the worldwide development and commercialization of smart chemotherapy CAP7.1REGENXBIO to Acquire Dimension TherapeuticsSanofi completes the acquisition of Protein SciencesSynlogic, Inc. has acquired Mirna Therapeutics, Inc.Topas Therapeutics signs multi-year research and option agreement with Lilly focused on immune toleranceWuXi Biologics and Gloria Pharmaceuticals Announce the Licensure of the Fully Human PD-1 Antibody, GLS-010, to Arcus BiosciencesXOMA Announces Transformational License Agreements for Gevokizumab and its IL-1 Beta Intellectual Property PortfolioAbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid TumorsABIVAX and Evotec enter into Strategic Collaboration to Develop Novel Antiviral AgentsAplagon Partners with Cadila Pharmaceuticals to Develop and Commercialize APAC First-in-Class Antithrombotics for the Prevention of Blood Vessel Occlusions Related to Vascular InterventionsArcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical Co. Ltd.BioNTech AG Enters into Licensing Agreement with CELLSCRIPT, LLC as it Advances Development of Messenger RNA Encoding Bispecific Antibodies and other Therapeutic ProteinsBioverativ and Bicycle Therapeutics Enter into Strategic Research Collaboration to Develop Therapies for Hemophilia and Sickle Cell DiseaseBoehringer Ingelheim and Gubra collaborate to develop next generation obesity treatmentsBristol-Myers Squibb and Halozyme Enter Global Collaboration and License Agreement for ENHANZE TechnologyCARDIOME ANNOUNCES AGREEMENT WITH BASILEA FOR DISTRIBUTION OF ZEVTERA/MABELIO (CEFTOBIPROLE) IN EUROPE AND ISRAELCatalent Signs Commercial Manufacturing Agreement with US WorldMeds for LofexidineCocrystal Pharma, HitGen and InterX Enter into Drug Discovery CollaborationCooper Pharma and BioQ Pharma Enter into Strategic Partnership for Ropivacaine ReadyfusOR in MoroccoCryoport Selected to Support the Potential Commercial Launch of Kite Pharma’s CAR-T Therapy Axicabtagene CiloleucelGeom Therapeutics Announces Agreement with National Institute of Allergy and Infectious Diseases (NIAID) for Clinical Advancement of GT-1HITGEN and TAKEDA Enter DNA-Encoded Library Based Drug Discovery Research CollaborationImmune Therapeutics, Inc. Announces Exclusive Agreement for Sale of Lodonal in Kenya Valued at Over $31 MillionInotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in-Class Gene Therapies for Rare DiseasesInventiva announces exercise of option by Boehringer Ingelheim to jointly develop potential new treatments for idiopathic pulmonary fibrosis (IPF)Kamada Announces Collaboration with BGN Technologies for Advanced Alpha-1 Antitrypsin Research with a Focus on Mechanism of ActionMARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTOMD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myeloid Leukemia TherapiesMediSix Therapeutics Signs Exclusive Licensing Agreement with the National University of SingaporeMerck KGaA Completes Divestment of Biosimilars BusinessMerck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-OncologyMitsubishi Tanabe Pharma America Signs Agreement with Option Care for National Home Infusion ServicesMoleculin to Collaborate on Combining its WP1122 Brain Cancer Drug Candidate with Roche’s Drug AvastinMustang Bio Announces Expansion of CAR T Pipeline into CD20-Directed Immunotherapy’sOnxeo Grants Exclusive Worldwide License of Validive developed for the treatment of oral severe mucositis to Monopar TherapeuticsOXIS ACQUIREs GEORGETOWN TRANSLATIONAL PHARMACEUTICALSPalatin Technologies Announces Signing of Licensing Agreement with Fosun Pharma Rights to Bremelanotide in China and Other Selected TerritoriesPanacea Biotech & Apotex Inc. expand collaboration to launch Prasugrel in USAPetra Pharma and Schrödinger Announce Research CollaborationPharmaCyte Restructures Agreements with Austrianova to Strengthen PartnershipPhosplatin Therapeutics Announces Collaboration with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate Combination of PT-112 and Avelumab in Phase I / II StudiesPulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plcQ BioMed Announces Development Partnership with Sphaera PharmaRealist Pharma and GlycoNet Announce CollaborationTakeda and Noile-Immune Biotech Collaborate to Advance Next Generation CAR-T Cell Therapy Effective for Solid TumorsZavante Therapeutics Announces Agreement with NIAID to Assess ZOLYD for Lower Respiratory Tract InfectionsZealand and Orbit Discovery enter into research collaborationAmgen announces new T-cell collaborationAthersys and Nikon CeLL Innovation to Collaborate on MultiStem Commercial Manufacturing in JapanBoryung to sell antihypertensive drugs in SE AsiaBreckenridge Pharmaceutical, Inc. Announces Acquisition of 5 ANDA’sBristol-Myers Squibb (BMY) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASHDURECT and Indivior PLC Sign a $17.5 Million Patent Purchase AgreementGamaMabs and MedImmune Enter Licensing Agreement to Develop Antibody Drug Conjugate Targeting CancerHarmony Biosciences Acquires US Rights to Pitolisant from Bioprojet; Raises $270 Million in Equity FinancingKaleido Biosciences and CoreBiome Partner to Accelerate Microbiome Therapeutic DevelopmentLilly and CureVac Announce Global Collaboration to Develop mRNA Cancer VaccinesLupin Acquires Symbiomix Therapeutics LLCMD Anderson and BridgeBio Pharma launch Navire Pharma to develop targeted therapy for patients with difficult-to-treat cancerMediWound Further Expands NexoBrid’s Global Outreach through New Distribution Agreement in Taiwan with Holy Stone HealthcareNeothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health CompanyRecursion Pharmaceuticals Announces Research Collaboration with Takeda to Rapidly Build a Rare Disease PipelineRegeneron Announces New Collaborations with HHS to Develop Antibodies against Ebola, Influenza and Multiple Other Emerging PathogensRevive Therapeutics Enters into Research Collaboration with Sanyal Biotechnology for Liver DiseasesShangPharma Innovation and SRI International Announce Drug Discovery CollaborationSouthern Research-Bionetix Collaboration Seeks Novel Cancer Drug That Targets a Genetic SwitchSpero Therapeutics Licenses Exclusive Rights to SPR994, a Novel Oral Carbapenem Being Studied for Use in AdultsTeijin Signs Exclusive License and Co-Development Agreement for Novel Botulinum Toxin in JapanTransgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid TumorsZealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaborationCook Pharmica Sells to Catalent in $950 Million BiopharmaAcquisition of AmetopApplied BioMath, LLC Announces Collaboration with Syntimmune for Pharmacokinetic and Pharmacodynamic Modeling in Clinical Program for Autoimmune DiseasesHanAll Biopharma and Harbour BioMed Sign Collaboration and License Agreement to Develop Two Novel Biologic Therapies in Greater ChinaAvinger Secures Waiver and Consent to CRG Loan AgreementIdorsia announces collaboration with Janssen Biotech on aprocitentan (ACT-132577)CARDIOME ANNOUNCES STRATEGIC LICENSING AGREEMENT TO COMMERCIALIZE AGGRASTAT IN RUSSIAArena Pharmaceuticals and Everest Medicines Enter into Development and Commercialization Partnership for Ralinepag and Etrasimod in ChinaProposed acquisition of VamoussevTv Therapeutics and Reneo Pharmaceuticals Enter Licensing Agreement for PPAR-Delta ProgramPrime Therapeutics Signs Outcomes-Based Contract with Novo Nordisk for Type 2 Diabetes Drug Victoza (liraglutide)reMYND Enters Into License Agreement to Further Develop Novel Treatments Improving Beta-cell Health and Insulin Signalling With Novo NordiskHitachi to Install New Proton Beam Therapy System in SpainAlexion and Halozyme Enter License Agreement for ENHANZE TechnologyAstellas, the Institute of Medical Science of the University of Tokyo, Chiba University, and Asahi Kogyosha Enter into Collaborative Research Agreement on Rice-based Oral Vaccine “”MucoRice””DiCE Molecules Announce Multi-Year Research Collaboration with GenentechCyclenium Pharma Announces Drug Discovery Collaboration Agreement with Ono PharmaceuticalEloxx Pharmaceuticals Completes Acquisition Transaction with Sevion TherapeuticsMallinckrodt Completes Acquisition of Ocera Therapeutics and OCR-002, Its Proprietary Therapy in Development for Treatment of Hepatic EncephalopathyMallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 BillionX-Chem and Abilita Bio Announce a Joint Research CollaborationAlnylam and Sanofi Submit Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for Patisiran for the Treatment of Hereditary ATTR (hATTR) AmyloidosisCancer Research UK announces drug discovery collaboration with Celgene CorporationFortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Diseases With Unmet Medical NeedsCSL and Vitaeris Announce Strategic Partnership with Option to AcquireClearPath Development Company Launches Third Collaboration Under Strategic Partnership With Astellas Pharma To Develop Staphylococcus Aureus Vaccine With Boston Children’s HospitalBasilea extends existing license agreement with Pfizer for antifungal Cresemba® (isavuconazole) to Chin
a and Asia PacificRegional development and commercialisation agreement finalised with China Medical System Holdings LimitedScientists from SRI International and Collaborations Pharmaceuticals, Inc. Identify Potential New Ebola Virus TherapyGlobavir Announces Partnership with SingHealth Duke-NUS Academic Medical Centre to Study Dengue TreatmentNovasep Signs Manufacturing Agreement with Clinical-stage Biopharmaceutical Company Tetraphase for Eravacycline APIGalapagos exercises co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countriesSelexis SA and Turgut Pharmaceuticals Advance Partnership with Third Commercial License AgreementPfizer Enters into Agreement to Develop and Commercialize CRESEMBA® (isavuconazole) in China and Asia Pacific RegionBiogen and Ionis Enter into New Collaboration to Identify Novel Therapies for the Treatment of Spinal Muscular AtrophyEvgen Pharma and King’s collaborate to advance therapy for ischaemic strokeAutifony Therapeutics and Boehringer Ingelheim collaborate on a novel therapeutic approach to a range of CNS disordersAUSSIE CANNABIS COMPANY SIGNS 10-YEAR DISTRIBUTION DEAL IN SWITZERLANDCerveau Technologies, Inc. Signs Research Agreement with KU Leuven University, BelgiumQ Therapeutics Announces Research Collaboration With REPROCELLConfo Therapeutics Enters Into Drug Discovery Collaboration with RocheIonis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Study in Patients with Huntington’s DiseasePixarBio Corporation Announces Signed Agreement with Lubrizol’s Division, Particle Sciences, to cGMP Manufacture NR14 for Clinical Trials, a 14 Day Post-Surgical Pain TreatmentHelomics Corporation and Ariel Precision Medicine, Inc. sign a services agreement to Advance Clinical Genomics in Precision Medicine ApplicationsANI Pharmaceuticals Acquires Four NDAs from AstraZeneca for $46.5 MillionHIKMA REACHES LICENSING AGREEMENT WITH CELLTRION FOR THIRD BIOSIMILAR PRODUCT IN THE MIDDLE EAST AND NORTH AFRICARevive Therapeutics Enters into Collaboration Agreement with Health Canada Licensed Dealer for Medical Cannabis and US FDA Approved LaboratoryNew partnership for the commercialization of Nucynta in the U.S. territoryAstellas Acquires Mitobridge Under Existing CollaborationXspray Pharma Enters Manufacturing Agreement With NerPharMa for its Lead Product Candidate – HyNap-DasaSmart Cannabis and SinglePoint Finalize Multifaceted Joint Venture AgreementCannabis Wheaton Income Corp. Announces Sustainable Growth Strategic Capital Corp. as New Wheaton Streaming PartnerDaiichi Sankyo and Translational Sciences Conclude Agreement, after Successful Phase 1a Trial, as Part of Daiichi Sankyo Portfolio PrioritizationTorrent Pharma completes acquisition of branded business of India and Nepal from UnichemMustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T TherapiesPharmaJet and Invectys partner in phase II clinical trial of DNA Cancer VaccineAmbrx and TRACON Pharmaceuticals Announce Development and Commercialization Agreement for TRC105 in ChinaGilead Sciences and Kite to Acquire Cell Design LabsRXI Pharma (RXII) Announces Research Collaboration with Center for Cancer Immune Therapy at Herlev HospitalCloaked TherapeuticsDelSiTech Ltd and C-Tri Co. Ltd Sign a Collaboration Agreement to Develop Innovative Drug Delivery Technology Product for OncologyVernalis plc enters into research collaboration with Daiichi SankyoI-Mab Biopharma signs licensing agreement for HyLeukin with GenexineMorphoSys Signs Regional License Agreement for Antibody MOR202 with I-MabRegeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology CollaborationJanssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer TherapyJuno Therapeutics Signs Licensing Agreements with Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center to Advance Its BCMA-Directed Engineered T Cell Program in Multiple Myeloma with Gamma Secretase InhibitionNovel Clinical Study Collaboration Announced Designed to Improve Clinical Care for Hemophilia Patients through Innovative Personalized TreatmentJacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics MarketGenerex Announces Collaboration with Shenzhen BioScien Pharmaceuticals to Develop and Commercialize the AE37 Immunotherapeutic Vaccine for the Treatment of Prostate Cancer in Chinabluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer ImmunotherapyJuno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing PartnershipBioInvent and Transgene collaborate on next generation oncolytic viruses encoding an anti-CTLA-4 antibody to treat solid tumorsFive Prime Therapeutics and Zai Lab Announce Exclusive License Agreement for FPA144 Anti-FGFR2b Antibody in Greater China and Global Strategic Development CollaborationEvotec Enters into Research Collaboration with CRTD to Discover Novel Therapies for Retinal DiseasesHistogenics Corporation and MEDINET Co., Ltd Enter Into Licensing Agreement for Development and Commercialization of NeoCart for the Japanese MarketAerogen Pharma and Lyomark Pharma Partner to Develop Inhaled Surfactant, Begin a Phase 2 Clinical Trialnnovus Pharma Expands International Distribution by Signing an Exclusive Agreement in Peru with Pharma Solutions for Zestra, Zestra Glide, EjectDelay and Sensum+Millendo Therapeutics Announces Acquisition of Alizé Pharma SAS to Expand
Orphan Endocrinology PipelineRECORDATI: ACQUIRES TRANSIPEG, TRANSIPEGLIB AND COLOPEG FOR THE FRENCH MARKETUltragenyx Sells Priority Review Voucher for $130 millionMesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulaeXCELL BIOLOGIX signs exclusive worldwide licensing agreement with the Wake Forest Institute for Regenerative Medicine for development and commercialization of novel tissue regeneration technology for healing chronic wounds and severe burnsVeru Acquires Novel Proprietary Formulation for Overactive BladderBioVectra Signs Iron Citrate Expansion Agreement with Keryx BiopharmaceuticalsRockwell Medical Signs Exclusive License Agreement with Quimica Europea to Commercialize Triferic in PeruTesoRx Pharma And ASKA Pharmaceutical Expand Territory And Scope Of Partnering Agreement For TesoRx’s Oral Testosterone ProductARDELYX ANNOUNCES LICENSE AGREEMENT WITH SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL DEVELOPMENT COMPANY LIMITED FOR TENAPANOR IN CHINAEarth Science Tech Enters Negotiations for MSN-2 and Nanoderm Distribution in Three Countries and Plans New Clinical Study with HIV-Seropositive and AIDS PatientsNavamedic ASA: Enters into partnership agreement for distribution of Zorflex in Sweden and FinlandPerkinElmer Completes Acquisition of EUROIMMUNAprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan DrugsKARTELL ENTERS BIO-ON TO HELP DEVELOP NEW TECHNOLOGIESRegeneron and Decibel Therapeutics collaboratesRoche and Ignyta Reach Definitive Merger AgreementArray BioPharma Announces Strategic Collaboration with PfizerShire and Rani Therapeutics Enter into Collaboration to Evaluate Use of the Rani Pill(TM) Technology for the Oral Delivery of Factor TherapyTOMI Environmental Solutions, Inc. Expands Presence in the United Kingdom With New Distribution AgreementOtsuka and X-Chem Enter into a Drug Discovery Research and License Collaboration
Please send an inquiry to email@example.com by using “Deals and Developments TOC” as subject.